Feedback / Questions
Undisclosed NPM1 targeted autologous TCR-based cell therapy - BlueSphere Bio
Undisclosed miHA TCR cell therapy - BlueSphere Bio
Undisclosed individualized neoAgs targeted TCR cell therapy - BlueSphere Bio
https://www.globenewswire.com/news-release/2024/06/03/2892552/0/en/BlueSphere-Bio-Announces-IND-Clearance-of-its-First-in-Human-Candidate-and-New-Cell-Therapy-Portfolio-for-High-Risk-Leukemia-Patients.html
Jun 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next